← Leaderboards
Marina Boukhvalova
Sigmovir Biosystems, Inc.
$1,044,710
Attributed
$1,044,710
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $591.2K · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,044,710 · 2
By mechanism
N01$1,044,710 · 2
Top collaborators
No co-investigators on record.
Most similar at Sigmovir Biosystems, Inc.
Same institution · by research overlap
- Steve Hauschild$3,233,329
Others in their field
Other Emerging Leaders on “Contracts”
- Leonard Freedman · Leidos Biomedical Research, Inc.$811,365,654
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lynn Briscoe · Leidos Biomedical Research, Inc.$236,279,699
- Leonard Freedmand · Leidos Biomedical Research, Inc.$165,274,216
- Kimberly Smith · Ppd Development Lp$116,584,264
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$95,500,810
Research focus
ContractsInfectious Disease ModelEvaluationEfficacy TestingAnimal ModelAnimal Model DevelopmentCotton RatsLicensureRespiratory Syncytial Virus VaccinesStandardizationVirusMetadataParainfluenzaParamyxovirusCollectionBasic ScienceIn Vivo
Grant awards (3)
Task A07: Collection of Metadata from In Vivo Studies Performed Under Previous IDIQ Contract Mechanisms$80,435
N01 · FY2024 · AI · contact PI
Task A15: Cotton Rat Model for the Evaluation of RSV Vaccines and Therapeutics$373,053
N01 · FY2019 · AI · contact PI
Task A15: Cotton Rat Model for the Evaluation of RSV Vaccines and Therapeutics$591,222
N01 · FY2018 · AI · contact PI